These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7510145)

  • 1. Plasma P-selectin is increased in thrombotic consumptive platelet disorders.
    Chong BH; Murray B; Berndt MC; Dunlop LC; Brighton T; Chesterman CN
    Blood; 1994 Mar; 83(6):1535-41. PubMed ID: 7510145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
    Katayama M; Handa M; Araki Y; Ambo H; Kawai Y; Watanabe K; Ikeda Y
    Br J Haematol; 1993 Aug; 84(4):702-10. PubMed ID: 7692937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-thromboglobulin: differentiation between intravascular and extravascular platelet destruction.
    Han P; Turpie AG; Genton E
    Blood; 1979 Nov; 54(5):1192-6. PubMed ID: 91396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.
    Hiyoyama K; Wada H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Shiku H; Tahara T; Kato T
    Blood Coagul Fibrinolysis; 1997 Sep; 8(6):345-9. PubMed ID: 9351524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origin of P-selectin as a circulating plasma protein.
    Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
    Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
    Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
    Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):1081-1103. PubMed ID: 29078925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Galli M; Grassi A; Barbui T
    Thromb Haemost; 1996 Mar; 75(3):427-31. PubMed ID: 8701402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.
    Park YA; Waldrum MR; Marques MB
    Am J Clin Pathol; 2010 Mar; 133(3):460-5. PubMed ID: 20154285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
    Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
    Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic thrombocytopenic purpura].
    Aul C; Scharf RE; Königshausen T; Schneider W
    Klin Wochenschr; 1985 Feb; 63(3):123-32. PubMed ID: 4038757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of beta-thromboglobulin levels in diagnosing and treating consumptive and immune thrombocytopenia.
    Rubenstein MD; Wall RT
    Am J Hematol; 1981 Jun; 10(4):369-73. PubMed ID: 6166192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia.
    Lee SH; Looareesuwan S; Chan J; Wilairatana P; Vanijanonta S; Chong SM; Chong BH
    Thromb Haemost; 1997 Feb; 77(2):289-93. PubMed ID: 9157583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.